On 9th April, Thursday Mamata Banerjee’s government gave its nod to start medical trials for ‘passive immunisation’ of COVID-19 patients in Beliaghata ID Hospital, anti-bodies will be used from the blood plasma of cured patients, to treat critically ill COVID-19 patients on a trial basis.

The Council of Scientific and Industrial Research (CSIR) approached several states for the approval of the passive immunisation therapy by using ‘convalescent plasma’. No other state has accepted the ‘plasma treatment’ yet which makes Bengal the first state to approve.

As per the reports of TOI, Kerala has already got approval from the Indian Council of Medical Research (ICMR) for a similar plasma therapy, but it was the state’s own initiative.

According to reports, Bengal’s approval to CSIR also demands to submit necessary clearances from the Ethics Committee and Clinical Trials Registry-India.

Doctors of ID Hospital Beliaghata and scientists from CSIR’s Indian Institute of Chemical Biology in Kolkata will be working together for the chemical trials. This proposal is under process in several countries across the globe.

The Plasma treatment involves, patients who have already recovered from COVID-19, blood plasma will be drawn from them after a span of 4 weeks which will be injected into critically ill patients.

A special team of scientists from Indian Institute of Chemical Biology, Kolkata and Central Drug Research Institute, Lucknow are working together to achieve this. The programme includes medical trials and if found effective it’ll be followed by bio-banking and therapeutic use.

Share:
Photos

Photos